Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Held at the desk.
Email me when S 4472 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 4472. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill renews existing authority aimed at accelerating the availability of important treatments for amyotrophic lateral sclerosis (ALS). It is intended to help people living with ALS and the medical professionals who treat them by keeping support for rapid therapy access in place. The legislation reflects ongoing concern about timely treatment for this progressive disease.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 4472
3 free questions a day, no accountSponsors
- Sen. Murkowski, Lisa [R-AK] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 4472 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 4472 freeOr ask your AI assistant about S 4472 directly:
Add to Claude, ChatGPT or Cursor